View in EDS PDF Full Text

S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma.

Saved in:
Bibliographic Details
Title: S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma.
Authors: Lin Q; Department of Pharmacy, The Affiliated Hospital of Putian University, Putian, Fujian, China.; Pharmaceutical and Medical Technology College, Putian University, Putian, Fujian, China., Su J; Pharmaceutical and Medical Technology College, Putian University, Putian, Fujian, China., Fang Y; Pharmaceutical and Medical Technology College, Putian University, Putian, Fujian, China., Zhong Z; Pharmaceutical and Medical Technology College, Putian University, Putian, Fujian, China., Chen J; Pharmaceutical and Medical Technology College, Putian University, Putian, Fujian, China., Zhang C; Department of Hematology and Rheumatology, the Affiliated Hospital of Putian University, Putian, Fujian, China.
Source: Frontiers in oncology [Front Oncol] 2024 Feb 01; Vol. 14, pp. 1344669. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38361783
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lin+Q%22">Lin Q</searchLink>; Department of Pharmacy, The Affiliated Hospital of Putian University, Putian, Fujian, China.; Pharmaceutical and Medical Technology College, Putian University, Putian, Fujian, China.<br /><searchLink fieldCode="AU" term="%22Su+J%22">Su J</searchLink>; Pharmaceutical and Medical Technology College, Putian University, Putian, Fujian, China.<br /><searchLink fieldCode="AU" term="%22Fang+Y%22">Fang Y</searchLink>; Pharmaceutical and Medical Technology College, Putian University, Putian, Fujian, China.<br /><searchLink fieldCode="AU" term="%22Zhong+Z%22">Zhong Z</searchLink>; Pharmaceutical and Medical Technology College, Putian University, Putian, Fujian, China.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Pharmaceutical and Medical Technology College, Putian University, Putian, Fujian, China.<br /><searchLink fieldCode="AU" term="%22Zhang+C%22">Zhang C</searchLink>; Department of Hematology and Rheumatology, the Affiliated Hospital of Putian University, Putian, Fujian, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Feb 01; Vol. 14, pp. 1344669. <i>Date of Electronic Publication: </i>2024 Feb 01 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38361783
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2024.1344669
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1344669
    Titles:
      – TitleFull: S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lin Q
      – PersonEntity:
          Name:
            NameFull: Su J
      – PersonEntity:
          Name:
            NameFull: Fang Y
      – PersonEntity:
          Name:
            NameFull: Zhong Z
      – PersonEntity:
          Name:
            NameFull: Chen J
      – PersonEntity:
          Name:
            NameFull: Zhang C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2024 Feb 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1